Ulrik Niels Lassen

Ulrik Niels Lassen

Clinical Professor

Member of:

  • Clinical Oncology


Publication year:
All
41 - 50 out of 159Page size: 10
  1. 2011
  2. Published

    Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial

    Søgaard, R., Fischer, Barbara Malene Bjerregaard, Mortensen, Jann, Højgaard, Liselotte & Lassen, Ulrik Niels, May 2011, In: European Journal of Nuclear Medicine and Molecular Imaging. 38, 5, p. 802-9 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. 2012
  4. Published

    Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers

    Rohrberg, K. S., Olesen, R. K., Pfeiffer, P., Ladekarl, M., Pappot, Helle, Christensen, I. J., Høyer-Hansen, G., Sørensen, M., Skov, B. G., Buysschaert, I., Carmeliet, P. & Lassen, Ulrik Niels, Feb 2012, In: Acta oncologica (Stockholm, Sweden). 51, 2, p. 234-42 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours

    Lassen, Ulrik Niels, Nielsen, Dorte Lisbet, Sørensen, M., Winstedt, L., Niskanen, T., Stenberg, Y., Pakola, S., Stassen, J. & Glazer, S., 14 Feb 2012, In: B J C. 106, 4, p. 678-84 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer

    Dizon, D. S., Damstrup, L., Finkler, N. J., Lassen, Ulrik Niels, Celano, P., Glasspool, R., Crowley, E., Lichenstein, H. S., Knoblach, P. & Penson, R. T., Jul 2012, In: International Journal of Gynecological Cancer. 22, 6, p. 979-86 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer

    Holländer, C., Baeksgaard, L., Sorensen, M., Albertsson, P., Damstrup, L. & Lassen, Ulrik Niels, Sep 2012, In: Anticancer Research. 32, 9, p. 4019-23 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2013
  9. Published

    Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment

    van Herpen, C. M. L., Lassen, Ulrik Niels, Desar, I. M. E., Brown, K. H., Marotti, M. & de Jonge, M. J. A., 2013, In: Anti-Cancer Drugs. 24, 2, p. 204-11 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours

    Lassen, Ulrik Niels, Miller, W. H., Hotte, S., Evans, T. R. J., Kollmansberger, C., Adamson, D., Nielsen, Dorte Lisbet, Spicer, J., Chen, E., Meyer, T., Brown, K., Rafi, R. & Sawyer, M. B., 2013, In: Cancer Chemotherapy and Pharmacology. 71, 2, p. 543-549 7 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  11. Published

    Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme

    Lassen, Ulrik Niels, Sorensen, M., Gaziel, T. B., Hasselbalch, B. & Poulsen, H. S., 2013, In: Anticancer Research. 33, 4, p. 1657-1660 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma

    Spindler, K. G., Sørensen, M., Pallisgaard, N., Andersen, R., Havelund, B. M., Ploen, J., Lassen, Ulrik Niels & Jakobsen, L. A., 2013, In: Acta Oncologica. 52, 5, p. 963-970 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer: A Health Economic Decision Analysis

    Søgaard, R., Fischer, Barbara Malene Bjerregaard, Mortensen, Jann, Rasmussen, T. R. & Lassen, Ulrik Niels, 2013, In: Value in Health. 16, 1, p. 57-65 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next

ID: 4952653